Clinical Trial Update: Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing FIAsp (fast-acting insulin aspart) to insulin aspart, both used with insulin glargine and metformin, in adults with Ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)
• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2017-12-05